FHTX - Balance Sheet - Foghorn Therapeutics Inc.

Current Liabilities	67 M
Accounts Payable	3.78 M
Short-Term Debt	9.07 M
Other Current Liabilities	54.1 M
Non-Current Liabilities	263 M
Long-Term Debt	0
Other Non-Current Liabilities	263 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	55.5	80.3	345.8	101.1	92.8	15.0	40.0
Short Term Investments	188.3	153.7	293.6	53.2	93.0	0	0
Receivables	0	0	0	300.0	0	0	0
Inventory	0	0	0	0	0	0	0
Other Current Assets	5.9	6.1	5.6	5.3	9.8	1.9	0.4
Total Current Assets	249.6	240.2	345.8	459.6	190.7	16.9	40.4
PP&E	32.6	42.9	49.4	56.1	62.3	3.7	2.1
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	1.7	1.7	1.7	1.7	0.6
Other Long Term Assets	1.8	2.8	8.0	2.4	0.8	11 K	0
Other Assets	0	0	0	0	0	0	0
Total Assets	284.0	285.9	404.9	519.8	255.6	22.3	43.1
LIABILITIES
Accounts Payable	3.8	6.3	5.4	3.8	3.7	3.4	2.0
Short Term Debt	9.1	8.8	11.9	14.0	8.0	5.5	0
Other Current Liabilities	8.5	8.4	5.0	2.6	5.2	3.7	1.4
Total Current Liabilities	67.0	58.4	336.8	48.7	18.8	12.7	3.5
Long Term Debt	0	36.6	45.5	51.3	78.0	97.7	7.0
Deferred Tax Income	0	0	0	0	19.7	0	(0.5)
Other Liabilities	0	0	29 K	0.1	0	45 K	71.8
Total Liabilities	329.5	363.1	404.8	422.9	109.4	110.4	82.3
EQUITY
Common Stock	6 K	4 K	4 K	4 K	4 K	1 K	1 K
Retained Earnings	(558.2)	(471.6)	(373.1)	(264.3)	(162.9)	(94.1)	(43.0)
Other Accumulative Comprehensive Income/Loss	0.1	(0.8)	(4.0)	10 K	7 K	(86.6)	(0.6)
Total Equity	(45.5)	(77.2)	0.1	96.9	146.2	(88.0)	(39.3)
Total Liabilities and Equity	284.0	285.9	404.9	519.8	255.6	22.3	43.1
SHARES OUTSTANDING
Common Shares Outstanding	54.9	42.0	41.6	37.2	36.8	36.8	19.6

Free